Brunei Darussalam vs High income (World Bank): Measles-containing-vaccine second-dose (MCV2) immunization coverage
Brunei Darussalam
99.0%
in 2025
High income (World Bank)
91.0%
in 2025
Brunei Darussalam rank
1st
High income (World Bank) rank
2nd
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Brunei Darussalam
- High income (World Bank)
How they compare
Brunei Darussalam currently reports 99.0% against 91.0% in High income (World Bank), a difference of 8.0%.
That makes Brunei Darussalam's figure about 1.1 times High income (World Bank)'s.
Across all 26 years both countries report, Brunei Darussalam has been ahead every year.
Brunei Darussalam ranks 1st and High income (World Bank) ranks 2nd of 194 countries.
Brunei Darussalam has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Brunei Darussalam | High income (World Bank) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 94.9% | 65.6% | 29.3% | Brunei Darussalam |
| 2010s | 95.8% | 89.4% | 6.4% | Brunei Darussalam |
| 2020s | 98.7% | 91.5% | 7.2% | Brunei Darussalam |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Brunei Darussalam or High income (World Bank)?
- Brunei Darussalam, at 99.0% against 91.0% in High income (World Bank) as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Brunei Darussalam and High income (World Bank)?
- 8.0%, with Brunei Darussalam ahead.
- How many years of comparable data are there for Brunei Darussalam and High income (World Bank)?
- 26 years are reported by both, from 2000 to 2025.
- How do Brunei Darussalam and High income (World Bank) rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Brunei Darussalam ranks 1st and High income (World Bank) ranks 2nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.